Baseline data from a population-based study examining the health-related quality of life (HRQL) of MS patients about to begin disease modifying therapy was used to determine the factors associated with the HRQL of Saskatchewan adults with relapsing-remitting MS. Participants completed a self-report questionnaire regarding demographic and socioeconomic status, fatigue, comorbid medical conditions, disability level (EDSS), number of attacks in past 6 months, illness intrusiveness (Illness Intrusiveness Ratings Scale), depression (Beck Depression Inventory), and HRQL (SF-36 Health Status Survey). Multiple linear regression models were used to identify the factors associated with the physical and mental health summary scores of the SF-36. We found poorer physical HRQL in those who are female; older; not working; have musculoskeletal or respiratory problems; greater fatigue, higher disability scores, and more MS attacks. High illness intrusiveness; digestive system problems; genitourinary problems; and headaches were associated with poorer mental HRQL. Interestingly, we found an interaction between sex and age in mental HRQL, with worse mental health in older men but better mental health in older women. These findings may assist health care providers in identifying patients who may be at risk for decline in their HRQL, permitting appropriate and timely interventions. Multiple Sclerosis 2007; 13: 1038—1045. http://msj.sagepub.com
Warren S., Warren KGMult Scler. World Health Organization, 2001.
2.
Chang C-H., Cella D., Fernández O., Luque G., de Castro P., de Andrés C., Casanova B., Hernández MA, Prieto JM, Fernández VE, de Ramón E.Quality of life in multiple sclerosis patients in Spain. Mult Scler2002; 8: 527—31.
3.
Merkelbach S. , Sittinger H., Koenig J.Is there a differential impact of fatigue and physical disability on quality of life in multiple sclerosis?J Nerv Ment Dis2002; 190: 388—93.
4.
Shawaryn MA, Schiaffino KM, LaRocca NG, Johnston MVDeterminants of health-related quality of life in multiple sclerosis: the role of illness intrusiveness. Mult Scler2002; 8: 310—18.
5.
Solari A., Filippini G., Mendozzi L., Ghezzi A., Cifani S., Barbierj E. et al. Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosur Ps1999; 67: 158—62.
6.
Singer MA, Hopman WM, MacKenzie TAPhysical functioning and mental health in patients with chronic medical conditions . Quality of Life Research1999 ; 8: 687—91.
7.
Roberts G., Stuifbergen AKHealth appraisal models in multiple sclerosis. Soc Sci Med1998; 47: 243—53.
8.
Hakim EA, Bakheit Amo, Bryant TN, Roberts Mwh, McIntosh-Michaels SA, Spackman AJ et al. The social impact of multiple sclerosis — a study of 305 patients and their relatives. Disabil Rehabil2000; 22: 288—93.
9.
Aronson KJQuality of life among persons with multiple sclerosis and their caregivers . Neurology1997; 48: 74—80.
10.
Koch LC, Rumrill PD Jr.Illness and demographic correlates of quality of life among people with multiple sclerosis. Rehabil Psychol2001 ; 46: 154—64.
11.
Lankhorst GJ , Jelles F., Smits Rcf, Polman CH, Kuik DJ, Pfennings Lema et al. Quality of life in multiple sclerosis: the disability and impact profile (DIP). J Neurol1996; 243: 469—74.
12.
Rudick RA, Miller D., Clough JD, Gragg LA, Farmer RGQuality of life in multiple sclerosis: comparison with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol1992; 49: 1237—42.
13.
Solari A., Radice D.Health status of people with multiple sclerosis: A community mail survey. Neurol Sci2001; 22: 307—15.
14.
Vickery BG, Hays RD, Harooni R., Myers LW, Ellison GWA health-related quality of life measure for multiple sclerosis. Qual Life Res1995; 4: 187—206.
15.
Amato MP, Ponziani G., Rossi F., Liedl CL, Stefanile C., Rossi L.Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler2001; 7: 340—44.
16.
Janardhan Vbr.Quality of life in patients with multiple sclerosis: The impact of fatigue and depression. J Neurol Sci2002; 205: 51—58.
17.
Jønsson A., Dock J., Ravnborg MHQuality of life as a measure of rehabilitation outcome in patients with multiple sclerosis. Acta Neurol Scand1996; 93: 229—35.
18.
Nortvedt MW , Riise T.The use of quality of life measures in multiple sclerosis research. Mult Scler2003; 9: 63—72.
19.
Benito-León J., Morales JM, Rivera-Navarro J.Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis. Eur J Neurol2002; 9: 497—502.
20.
Cutajar R., Ferriani E., Scandellari C., Sabattini L., Trocino C., Marchello LP et al. Cognitive function and quality of life in multiple sclerosis patients. J Neurovirol2000; 6: S186—S90.
21.
Fruehwald S. , Loeffler-Stastka H., Eher R., Saletu B., Baumhackl U.Depression and quality of life in multiple sclerosis. Acta Neurol Scand2001; 104: 257—61.
22.
Kenealy PM, Beaumont JG, Lintern R., Murrell R.Autobiographical memory, depression and quality of life in multiple sclerosis . J Clin Exp Neuropsyc2000; 22: 125—31.
23.
Nicholl CR, Lincoln NB, Francis VM, Stephan TFAssessing quality of life in people with multiple sclerosis. Disabil Rehabil2001; 23: 597—603.
24.
Patti F., Cacopardo M., Palermo F., Ciancio MR, Lopes R., Restivo D. et al. Health-related quality of life and depression in an Italian sample of multiple sclerosis patients. J Neurol Sci2003; 211: 55—62.
25.
Provinciali L., Ceravolo MG, Bartolini M., Logullo F., Danni MAA multidimensional assessment of multiple sclerosis: relationships between disability domains . Acta Neurol Scand1999; 100: 156—62.
26.
The Canadian Burden of Illness Study Group.Burden of illness of multiple sclerosis: part II: quality of life. Can J Neurol Sci1998; 25: 31—38.
27.
Wang JL, Reimer MA, Metz LM, Patten SBMajor depression and quality of life in individuals with multiple sclerosis . Int J Psych Med2000; 30: 309—17.
28.
Grima DT, Torrance GW, Francis G., Rice G., Rosner AJ, Lafortune L.Cost and health-related quality of life consequences of multiple sclerosis . Mult Scler2000; 6: 91—98.
29.
Henriksson F. , Fredrikson S., Masterman T., Jönsson B.Costs, quality of life and disease severity in multiple sclerosis: a cross-sectional study in Sweden. Eur J Neurol2001; 8: 27—35.
30.
Parkin D., Jacoby A., McNamee P., Miller P., Thomas S., Bates D.Treatment of multiple sclerosis with interferon β: an appraisal of cost-effectiveness and quality of life. J Neurol Neurosur Psych2000; 68: 144—49.
31.
Rice GP, Oger J., Duquette O., Francis GS, Bélanger M., Laplante S., Grenier JFTreatment with interferon beta-1b improves quality of life in multiple sclerosis . Can J Neurol Sci1999; 26: 276—82.
32.
Somerset M., Peters TJ, Sharp DJ, Campbell R.Factors that contribute to quality of life outcomes prioritised by people with multiple sclerosis. Quality of Life Research2003; 12: 21—29.
33.
Brunet DG, Hopman WM, Singer MA, Edgar CM, MacKenzie TAMeasurement of health-related quality of life in multiple sclerosis patients . Can J Neurol Sci1996; 23: 99—103.
34.
Ford HL, Gerry E., Johnson MH, Tennants A.Health status and quality of life of people with multiple sclerosis . Disabil Rehabil2001; 23: 516—21.
35.
Janardhan B. , Bakshi R.Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis. Arch Neurol2000; 57: 1485—91.
36.
Miller DM, Rudick RA, Baier M., Cutter G., Doughtery DS, Weinstock-Guttman B. et al. Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Mult Scler2003; 9: 1—5.
37.
Modrego PJ, Pina MA, Simón A., Azuara MCThe interrelations between disability and quality of life in patients with multiple sclerosis in the area of Bajo Aragon, Spain: a geographically based survey. Neurorehab Neural Re2001; 15: 69—73.
38.
Murphy N., Confavreux C., Haas J., König N., Roullet E., Sailer M. et al. Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. J Neurol Neurosur Psych1998; 65: 460—66.
39.
Nortvedt MW , Riise T., Myhr KM, Nyland HIQuality of life in multiple sclerosis: measuring the disease effects more broadly. Neurol1999 ; 53: 1098—103.
40.
Nortvedt MW , Riise T., Myhr K-M., Nyland HIPerformance of the SF-36, SF-12, and RAND-36 Summary Scales in a multiple sclerosis population . Medical Care2000; 38: 1022—28.
41.
Nortvedt MW , Riise T., Myhr K-M., Nyland HIQuality of life as a predictor for change in disability in MS. American Academy of Neurology2000; 55: 51—54.
42.
O'Connor P. , Lee L., Tin Ng P., Narayana P., Wolinsky JSDeterminants of overall quality of life in secondary progressive MS: a longitudinal study . Neurol2001; 57: 889—91.
43.
Pfennings L. , Cohen L., Adèr H., Polman C., Lankhorst G., Smits R. et al. Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. J Neurol1999; 246: 587—91.
44.
Stuifbergen AK, Seraphine A., Roberts G.An explanatory model of health promotion and quality of life in chronic disabling conditions. Nursing Research2000; 49: 122—29.
45.
Vermersch P. , de Seze J., Delisse B., Lemaire S., Stojkovic T.Quality of life in multiple sclerosis: influence of interferon-β1a (Avonex®) treatment . Mult Scler2002; 8: 377—81.
46.
Somerset M. , Sharp D., Campbell R.Multiple sclerosis and quality of life: a qualitative investigation. J Health Serv Res2002; 7: 151—59.
47.
Rothwell PM , McDowell Z., Wong CK, Dorman PJDoctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. British Medical Journal1997; 314: 1580—83.
48.
Arnoldus JH , Killestein J., Pfennings LE, Jelles B., Uitdehaag BM, and Polman CHQuality of life during the first 6 months of interferon-beta treatment in patients with MS . Mult Scler2000; 6: 338—42.
49.
Ware JE, Snow KK, Kosinski M., Gandek B.SF-36 health survey: manual and interpretation guide. The Health Institute, New England Medical Centre, 1993.
50.
McHorney CA , Ware JE, Raczek AEThe MOS 36-item short-form health survey (SF-36): II. psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care1993 ; 31: 247—63.
51.
McHorney CA , Ware JE, Lu R., Sherbourne DCThe MOS 36-item short-form health survey (SF-36): III. tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care1994; 32: 40—66.
52.
Hopman WM, Towheed T., Anastassiades T., Tenenhouse A., Poliquin S., Berger C. et al. The Canadian Multicentre Osteoporosis Study Research Group. Canadian normative data for the SF-36 health survey. Can Med Assoc J2000; 163: 265—71.
Beck ATDepression: clinical, experimental, and theoretical aspects. Hoeber Medical Division, Harper and Row , 1967.
55.
Carroll LJ, Cassidy JD, Côté P.The Saskatchewan health and back pain survey: the prevalence and factors associated with depressive symptomatology in Saskatchewan adults. Can J Public Health2000; 91: 459—64.
56.
Carroll LJ, Mercado AC, Cassidy JD, Côté P.A population-based study of factors associated with combinations of active and passive coping with neck and low back pain. J Rehabil Med2002; 34: 67—72.
57.
Carroll LJ, Cassidy JD, Côté P.Depression as a risk factor for onset of an episode of troublesome neck and low back pain. Pain2004; 107: 134—39.
58.
Côté P. , Cassidy J., Carroll L.Is lifetime history of neck injury in a traffic collision associated with prevalent neck pain, headache and depressive symptomatology?Accid Anal Prev2000; 32: 151—59.
59.
Côté P. , Cassidy J., Carroll L.The factors associated with neck pain and its related disability in the Saskatchewan population. Spine2000; 25: 1109—17.
60.
Côté P. , Cassidy JD, Carroll LJThe treatment of spinal pain: who seeks care? Who goes where?Medical Care2001; 39: 956—67.
61.
Jaroszynski G. , Cassidy JD, Carroll LJ, Côté P., Yong-Hing K.Development and validation of a comorbidity scale Quebec, 1996.
62.
Mercado AC, Carroll LJ, Cassidy JD, Côté P.Coping with neck and low back pain in the general population. Health Psychology2000; 19: 333—38.
63.
Devins GM, Binik YM, Hutchinson TA, Hollomby DJ, Barre PE, Guttmann RDThe emotional impact of end-stage renal disease: importance of patients' perception of intrusiveness and control. Int J Psych Med1983—1984; 13: 327—43.
64.
Devins GM, Seland TPEmotional impact of multiple sclerosis: recent findings and suggestions for future research. Psychological Bulletin1987 ; 101: 363—75.
65.
Devins GM, Edworthy SM, Paul LC, Mandin H., Seland TP, Klein G. et al. Restless sleep, illness intrusiveness, and depressive symptoms in three chronic illness conditions: rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Psych Res1993; 37: 163—70.
66.
Devins GM, Edworthy SM, Seland TP, Klein GM, Paul LC, Mandin H.Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Nerv Ment Dis1993; 181: 377—81.
67.
Devins GM, Seland TP, Klein G., Edworthy S., Saary MJStability and determinants of psychosocial well-being in multiple sclerosis . Rehabil Psychol1993; 38: 11—26.
68.
Flanagan JCMeasurement of quality of life: current state of the art. Arch Phys Med Rehabil1982; 63: 56—59.
69.
Kurtzke JFRating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurol1983; 33: 1444—52.
70.
O'Connor P.Multiple sclerosis: the facts you need. Key Porter Books , 2002.
71.
Halper J.Advanced concepts in multiple sclerosis nursing care. Demos Medical Publishing Inc., 2001.
72.
Gulick EECorrelates of quality of life among persons with multiple sclerosis . Nurs Res1997; 46: 305—11.
